Slower-than-expected demand recovery
Customer destocking may persist longer than anticipated, delaying volume recovery and impacting Q4 guidance.
high · analyst_questionSudarshan Chemical Industries Ltd — Q3 FY26
Sudarshan Chemical reported a tough Q3 FY26, with the acquired Heubach/Clariant business posting a €38 million EBITDA loss, driven by customer destocking and weak demand in Euro...
bearish
high
✓ Verified against BSE filing
Risk Intelligence
Material risks this quarter
Concise cards keep the risk register scannable while preserving evidence-level context in the underlying quarter data.
Risks
Inventory reduction impact on reported EBITDA
Planned inventory reduction will temporarily depress reported EBITDA by €9-12 million, which may surprise investors.
medium · management_commentaryHigh fixed cost base in acquired business
The acquired group has a high fixed cost structure, making EBITDA highly sensitive to volume fluctuations.
high · analyst_questionEU-India trade deal uncertainty
Potential EU-India trade deal may take 10-12 months to implement, with no immediate benefit; global footprint provides flexibility.
low · management_commentary